Detalhe da pesquisa
1.
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Breast Cancer Res
; 16(1): R7, 2014 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24451109
2.
Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.
Blood
; 112(8): 3434-43, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18474728
3.
Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction.
Endocrinology
; 149(11): 5828-34, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18653707
4.
p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation.
J Pharmacol Exp Ther
; 324(3): 921-9, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18056868
5.
p38alpha-selective MAP kinase inhibitor reduces tumor growth in mouse xenograft models of multiple myeloma.
Anticancer Res
; 28(6A): 3827-33, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19189670
6.
Role of p38 mitogen activated protein kinase in a model of osteosarcoma-induced pain.
Pharmacol Biochem Behav
; 90(4): 664-75, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18584857
7.
Pharmacological properties of SD-282 - an alpha-isoform selective inhibitor for p38 MAP kinase.
Pharmacology
; 81(3): 204-20, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18176091
8.
Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
Anticancer Res
; 27(6B): 4149-57, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18229422
9.
A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model.
J Periodontol
; 78(10): 1992-8, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18062121
10.
Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness.
Eur J Pharmacol
; 544(1-3): 160-7, 2006 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-16843456
11.
Antinociceptive action of a p38alpha MAPK inhibitor, SD-282, in a diabetic neuropathy model.
Pain
; 109(3): 409-419, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15157702
12.
Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig.
J Inflamm Res
; 3: 9-16, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-22096353
13.
P38alpha-selective mitogen-activated protein kinase inhibitor for improvement of cultured human islet recovery.
Pancreas
; 39(4): 436-43, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20084046
14.
Analgesic effects of p38 kinase inhibitor treatment on bone fracture healing.
Pain
; 142(1-2): 116-26, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19167815
15.
p38 MAPK inhibition reduces diabetes-induced impairment of wound healing.
Diabetes Metab Syndr Obes
; 2: 91-100, 2009 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21437122
16.
Selective p38α mitogen-activated protein kinase inhibitor attenuates lung inflammation and fibrosis in IL-13 transgenic mouse model of asthma.
J Asthma Allergy
; 1: 31-44, 2008 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21436983
17.
Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation.
Eur J Pharmacol
; 600(1-3): 117-22, 2008 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-18926814
18.
A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.
J Pharmacol Exp Ther
; 320(1): 56-63, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17041006
19.
Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Mol Pharmacol
; 72(1): 152-61, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17400764
20.
Effect of transforming growth factor-beta receptor I kinase inhibitor 2,4-disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling.
J Pharmacol Exp Ther
; 319(2): 586-94, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16888081